Similar articles

• Leflunomide immunosuppression in rat small intestinal transplantation.

  Foster PF, Xiao F, Kociss K, Chong AS, Sankary HN, McChesney L, Cohn S, Williams JW. Foster PF, et al. Transplant Proc. 1994 Jun;26(3):1599-600. Transplant Proc. 1994. PMID: 8030053 No abstract available.
• Immunosuppression by combined liver transplantation in the rat mechanisms of graft acceptance and regulation of graft-vs-host disease.

  Kobayashi E, Kamada N, Enosawa S, Toyama N, Lord R, Stamatiou S, Delriviere L, Miyata M. Kobayashi E, et al. Transplant Proc. 1994 Jun;26(3):1575-7. Transplant Proc. 1994. PMID: 8030042 No abstract available.
• The effect of rapamycin on orthotopic small bowel transplantation in the rat.

  Chen H, Wu J, Xu D, Aboujaoude M, Stepkowski S, Kahan B, Daloze P. Chen H, et al. Transplant Proc. 1992 Jun;24(3):1157-8. Transplant Proc. 1992. PMID: 1604567 No abstract available.
• Immunologic basis of allograft rejection and immunosuppressive agents in intestinal transplantation.

  Vianna R. Vianna R. Minerva Pediatr. 2009 Jun;61(3):293-303. Minerva Pediatr. 2009. PMID: 19461573 Review.
• [Everolimus: immunosuppression with antilymphoproliferative therapy].

  Pascual J. Pascual J. Nefrologia. 2004;24(2):112-23. Nefrologia. 2004. PMID: 15219086 Review. Spanish. No abstract available.